Literature DB >> 7703749

Apolipoprotein E genotype and association between smoking and early onset Alzheimer's disease.

C M van Duijn1, L M Havekes, C Van Broeckhoven, P de Knijff, A Hofman.   

Abstract

OBJECTIVE: To investigate the hypothesis that differential survival between smokers and non-smokers leading to a decrease in the frequency of the e4 allele of the apolipoprotein E gene may explain the inverse relation between smoking history and early onset Alzheimer's disease.
DESIGN: A population based case-control study.
SETTING: The four northern provinces of the Netherlands and metropolitan Rotterdam.
SUBJECTS: 175 patients with early onset Alzheimer's disease and two independent control groups of 159 and 457 subjects. MAIN OUTCOME MEASURES: Frequencies of the apolipoprotein e4 allele and relative risk of early onset Alzheimer's disease.
RESULTS: The inverse association between smoking history and early onset Alzheimer's disease could not be explained by a decrease in the frequency of the apolipoprotein e4 allele. Among carriers of this allele with a family history of dementia subjects with a history of smoking had a strongly reduced risk of early onset Alzheimer's disease (odds ratio 0.10 (95% confidence interval 0.01 to 0.87)).
CONCLUSIONS: The results suggest that the inverse relation between smoking history and early onset Alzheimer's disease cannot be explained by an increased mortality in carriers of the apolipoprotein e4 allele who smoke. The association is strongly modified by the presence of the apolipoprotein e4 allele as well as by a family history of dementia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7703749      PMCID: PMC2549007          DOI: 10.1136/bmj.310.6980.627

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  20 in total

1.  Cerebral blood flow in dementia.

Authors:  V C Hachinski; L D Iliff; E Zilhka; G H Du Boulay; V L McAllister; J Marshall; R W Russell; L Symon
Journal:  Arch Neurol       Date:  1975-09

2.  Apolipoprotein E genotyping by one-stage PCR.

Authors:  P R Wenham; W H Price; G Blandell
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

3.  Relation between nicotine intake and Alzheimer's disease.

Authors:  C M van Duijn; A Hofman
Journal:  BMJ       Date:  1991-06-22

4.  Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain.

Authors:  M E Benwell; D J Balfour; J M Anderson
Journal:  J Neurochem       Date:  1988-04       Impact factor: 5.372

5.  History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease.

Authors:  A Hofman; W Schulte; T A Tanja; C M van Duijn; R Haaxma; A J Lameris; V M Otten; R J Saan
Journal:  Neurology       Date:  1989-12       Impact factor: 9.910

6.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

7.  Aetiology of Parkinson's disease.

Authors:  D B Calne; J W Langston
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

Review 8.  Apolipoprotein E polymorphism and atherosclerosis.

Authors:  J Davignon; R E Gregg; C F Sing
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

9.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

Authors:  M C Chartier-Harlin; M Parfitt; S Legrain; J Pérez-Tur; T Brousseau; A Evans; C Berr; O Vidal; P Roques; V Gourlet
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

10.  Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

Authors:  A B Graves; C M van Duijn; V Chandra; L Fratiglioni; A Heyman; A F Jorm; E Kokmen; K Kondo; J A Mortimer; W A Rocca
Journal:  Int J Epidemiol       Date:  1991       Impact factor: 7.196

View more
  18 in total

1.  Smoking and the brain.

Authors:  C Brayne
Journal:  BMJ       Date:  2000-04-22

2.  Neuroprotection in Alzheimer's disease - new strategies for treatment.

Authors:  A Nordberg
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

3.  Occupational exposures to solvents and aluminium and estimated risk of Alzheimer's disease.

Authors:  A B Graves; D Rosner; D Echeverria; J A Mortimer; E B Larson
Journal:  Occup Environ Med       Date:  1998-09       Impact factor: 4.402

Review 4.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

Review 5.  Gene environment interaction.

Authors:  H Campbell
Journal:  J Epidemiol Community Health       Date:  1996-08       Impact factor: 3.710

Review 6.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

7.  An Exome-Wide Association Study Identifies New Susceptibility Loci for Age of Smoking Initiation in African- and European-American Populations.

Authors:  Keran Jiang; Zhongli Yang; Wenyan Cui; Kunkai Su; Jennie Z Ma; Thomas J Payne; Ming D Li
Journal:  Nicotine Tob Res       Date:  2019-05-21       Impact factor: 4.244

8.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

9.  Effect of Apolipoprotein E epsilon4 on the association between health behaviors and cognitive function in late midlife.

Authors:  Séverine Sabia; Mika Kivimaki; Meena Kumari; Martin J Shipley; Archana Singh-Manoux
Journal:  Mol Neurodegener       Date:  2010-06-01       Impact factor: 14.195

10.  Effects of nicotine and mecamylamine on cognition in rhesus monkeys.

Authors:  Simon N Katner; Sophia A Davis; Amber J Kirsten; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2004-04-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.